Tianjin Eleli Technology Development
Tirzepatide
Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Tianjin Eleli Technology Development between 29 Jan 2026 and 4 Mar 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Tianjin Eleli Technology Development
Tirzepatide
Tested 4 Samples
Last test 4 Mar 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Tianjin Eleli Technology Development
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
4 Mar 2026
First
29 Jan 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 4 Mar 2026 | View | 30mg | 29.7mg | -1.0% | 98.11% | 12/2025 | No Label / Silver Crimp / Gray Cap | Lab E | Public | |
| 4 Mar 2026 | View | 30mg | 44.8mg | +49.3% | 99.19% | 1/2026 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 11 Feb 2026 | View | 40mg | 42.3mg | +5.8% | 99.90% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 29 Jan 2026 | View | 30mg | ⚠️ Sample does not contain Tirzepatide | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |||